Danhong Injection in the Treatment of Acute Ischemic Stroke
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01677208 |
|
Recruitment Status :
Recruiting
First Posted : August 31, 2012
Last Update Posted : October 9, 2018
|
Sponsor:
China Academy of Chinese Medical Sciences
Collaborator:
China Food and Drug Administration
Information provided by (Responsible Party):
Zhong Wang, China Academy of Chinese Medical Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2019 |
| Estimated Study Completion Date : | June 2019 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):